AN-0128

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameAN-0128
Drug Alias NameBorinic acid ester - AnacorCRM-0005ONT-0001AN-0128
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTumor necrosis factor α inhibitors
TargetsTumor necrosis factor α
Therapy Area/IndicationsDermatitis, AtopicDental Plaque
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAnacor Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer IncAnacor Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsDermatitis, AtopicDental Plaque

Other Information

ATC CodeN/A
Related LinksDrugBank